Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPARGNE: Sirolimus vs Tacrolimus After Kidney Transplantation
NCT00811915Phase 3Terminated
- Sponsor
- Rouen University Hospital
- Start
- Jan 2009
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of sirolimus in kidney transplantation (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Incidence of a composite endpoint (worsening of GFR, cancer, diabetes) at 24 months. Started Jan 2009; status: terminated.
02
Drugs
sirolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00811915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811915.